|
TTC27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82080017729902E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.91310350578556E-11 |
| Normal-vs-Stage2 |
2.580200E-03 |
| Normal-vs-Stage3 |
1.79609999999553E-05 |
| Normal-vs-Stage4 |
1.991480E-04 |
| Stage1-vs-Stage2 |
6.072400E-01 |
| Stage1-vs-Stage3 |
1.786830E-01 |
| Stage1-vs-Stage4 |
3.242200E-01 |
| Stage2-vs-Stage3 |
7.702000E-01 |
| Stage2-vs-Stage4 |
8.595400E-01 |
| Stage3-vs-Stage4 |
8.893400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16829887378367E-11 |
| Normal-vs-AfricanAmerican |
2.711800E-01 |
| Normal-vs-Asian |
9.246100E-04 |
| Caucasian-vs-AfricanAmerican |
8.962000E-04 |
| Caucasian-vs-Asian |
5.924400E-01 |
| AfricanAmerican-vs-Asian |
3.712000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.67250002525554E-09 |
| Normal-vs-Female |
1.83589998759004E-09 |
| Male-vs-Female |
4.045000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.562400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.26579999815135E-08 |
| Normal-vs-Age(61-80Yrs) |
6.39050035111666E-10 |
| Normal-vs-Age(81-100Yrs) |
1.104840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.152400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.922400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.242800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.607600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.416000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.549780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.51438999999032E-05 |
| Normal-vs-Grade 2 |
3.82780473984212E-11 |
| Normal-vs-Grade 3 |
2.71040000443534E-08 |
| Normal-vs-Grade 4 |
1.168210E-02 |
| Grade 1-vs-Grade 2 |
5.025400E-01 |
| Grade 1-vs-Grade 3 |
2.504600E-01 |
| Grade 1-vs-Grade 4 |
4.565600E-02 |
| Grade 2-vs-Grade 3 |
2.072800E-01 |
| Grade 2-vs-Grade 4 |
3.627600E-02 |
| Grade 3-vs-Grade 4 |
2.539200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
3.497300E-03 |
| ccA subtype-vs-ccB subtype |
3.51639994899955E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.87100001947505E-09 |
| Normal-vs-N1 |
2.544200E-02 |
| N0-vs-N1 |
6.897000E-01 |
|
|
